Future Horizons in the European Cancer Diagnostics Market -France, Germany, Italy, Spain, UK: Supplier Shares and SalesFor...
cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expandingfield. Anticipated technolog...
14. Human Chorionic Gonadotropin (HCG)15. Insulin16. NSE17. Occult Blood18. PAP Smear/HPV19. Prostatic Acid Phosphatase (P...
Cachectin (TNT)CalmodulinECFRNerve Growth Factor (NGF)Epidermal Growth Factor (EGF)Ornithine DecarboxylaseTransferrinTrans...
DR-70DU-PAN-2Endometrial Bleeding Associated FactorEndostatinEpithelial Membrane AntigenFeulgen HydrolysisFibronectinFSH(1...
NMP22OA-519Opiod PeptidesP-glycoproteinPancreatic Oncofetal Antigen (POA)Placental LactogenPR92Proliferative Index, Ki-67P...
15. J&J Vitros 560016. Olympus AU540017. Olympus AU3000i18. Olympus AU270019. Roche Modular Analytics20. Roche Cobas Integ...
Immuno-PCRQC-PCRCARDNAHPALCRNASBAQBRSDA3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute...
C. Market StructureD. Market Size, Growth and Major SuppliersSpainA. Executive SummaryB. Business EnvironmentC. Market Str...
ArcaBeckman Coulter/DanaherBecton DickinsonBiomedical DiagnosticsbioMerieuxBio-RadCepheidCorrelogic SystemsDakoDecodeDiade...
Targeted Diagnostics & TherapeuticsTosohVeridexWako Pure ChemicalsWallac/PEZilaAppendixesAppendix I: Major Universities an...
Major Companies Developing or MarketingNSE TestsMajor Companies Developing or MarketingOccult Blood TestsMajor Companies D...
France, Hospital Laboratories Major TumorMarker Test Volume Forecast by TestFrance, Commercial/Private LaboratoriesMarker ...
and Diagnostics Sales Forecastby Market SegmentFrance, Gastrin Test Volumeand Diagnostics Sales Forecastby Market SegmentF...
Forecast by Market SegmentFrance, PSA Test Volume and Diagnostics SalesForecast by Market SegmentFrance, S-100 Protein Tes...
Sales by Major SupplierExecutive Summary Table: Germany, TotalTumor Marker Test Volume and Sales ForecastBy Market Segment...
Germany, CA-15-3/27.29 Test Volume andDiagnostics Sales Forecast by Market SegmentGermany, CA-19 Test Volume and Diagnosti...
Sales Forecast by Market SegmentGermany, Occult Blood Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, O...
by Market SegmentGermany, TPA Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Total Tumor Marker Sales...
Tumor Marker Forecast by TestItaly, Commercial/Private LaboratoriesMajor Tumor Marker Sales Forecastby TestItaly, ACTH Tes...
And Diagnostics Sales Forecastby Market SegmentItaly, NSE Test Volume and Diagnostics SalesForecast by Market SegmentItaly...
by Market SegmentItaly, TPA Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Total Tumor MarkersSales by ...
Spain, CA 15-3 Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, CA 19-9 Test Volume and DiagnosticsSales ...
And Diagnostics Sales Forecastby Market SegmentSpain, Progesterone ReceptorTest Volume and Diagnostics Sales Forecastby Ma...
Sales by Major SupplierSpain, PSA Testing Market DiagnosticsSales by Major SupplierExecutive Summary Table: U.K., TotalTum...
by Market SegmentU.K., CA 19-9 Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., CA-125 Test Volume and Dia...
Sales Forecast by Market SegmentU.K., PAP Smear Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Parathyro...
Contact: sales@reportsandreports.com for more information.
Upcoming SlideShare
Loading in …5
×

Future Horizons in the European Cancer Diagnostics Market - France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country

193 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
193
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Future Horizons in the European Cancer Diagnostics Market - France, Germany, Italy, Spain, UK: Supplier Shares and Sales Forecasts for 40 Tumor Markers by Country

  1. 1. Future Horizons in the European Cancer Diagnostics Market -France, Germany, Italy, Spain, UK: Supplier Shares and SalesForecasts for 40 Tumor Markers by CountryReport Details:Published:September 2012No. of Pages: 820Price: Single User License – US$18500This unique report provides information not available from any other published source, includingvolume, sales, and leading supplier shares by test.This comprehensive five-country reportidentifies and evaluates major business opportunities emerging in the cancer diagnostics marketduring the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviewscurrent and emerging tests; analyzes potential applications of various diagnostic technologies;forecasts sales of major tumor markers by country and market segment; profiles leading marketplayers and potential entrants; and suggests alternative business expansion strategies forsuppliers.The cancer diagnostics market is on the verge of explosion, as the researchersapproach major technological breakthroughs in tumor diagnosis and therapy, discover newspecific antigens, and unlock the mystery of the genetic basis of the disease.; During the next fiveyears, the European cancer diagnostic testing market is promising to be an exciting, dynamic andrapidly expanding field. Anticipated technological breakthroughs will create numerousopportunities for determining genetic predisposition, detecting specific tumors, and monitoringbiological response to cancer therapy.; The rise in geriatric population will further compound thegrowing demand for malignancy assays and the rapid market expansion.This unique report provides information not available from any other published source, includingvolume, sales, and leading supplier shares by test. This comprehensive five-country reportidentifies and evaluates major business opportunities emerging in the cancer diagnostics marketduring the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviewscurrent and emerging tests; analyzes potential applications of various diagnostic technologies;forecasts sales of major tumor markers by country and market segment; profiles leading marketplayers and potential entrants; and suggests alternative business expansion strategies forsuppliers.The cancer diagnostics market is on the verge of explosion, as the researchers approach majortechnological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, andunlock the mystery of the genetic basis of the disease. During the next five years, the European
  2. 2. cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expandingfield. Anticipated technological breakthroughs will create numerous opportunities for determininggenetic predisposition, detecting specific tumors, and monitoring biological response to cancertherapy. The rise in geriatric population will further compound the growing demand for malignancyassays and the rapid market expansion.Get your copy of this report @http://www.reportsnreports.com/reports/192162-future-horizons-in-the-european-cancer-diagnostics-market-france-germany-italy-spain-uk-supplier-shares-and-sales-forecasts-for-40-tumor-markers-by-country.htmlMajor points covered in Table of Contents of this report includeTable of ContentsIntroductionWorldwide Market and Technology OverviewA. Cancer Statistics and Etiology1. Brest Cancer2. Lung Cancer3. Colon and Rectum Cancer4. Prostate Cancer5. Stomach Cancer6. Leukemia7. Lymphoma8. Oral Cancer9. Skin Cancer10. Uterine Cancer11. Ovarian Cancer12. Bladder CancerB. Major Current And Emerging Cancer Diagnostic Tests1. Introduction2. Tumor Marker Classification3. ACTH4. Alpha-Fetoprotein (AFP)5. Beta-2 Microglobulin6. CA 15-3/27.297. CA 19-98. CA-1259. Calcitonin10. Carcinoembrionic Antigen (CEA)11. Estrogen and Progesterone Receptors12. Ferritin13. Gastrin
  3. 3. 14. Human Chorionic Gonadotropin (HCG)15. Insulin16. NSE17. Occult Blood18. PAP Smear/HPV19. Prostatic Acid Phosphatase (PAP)20. Prostate-Specific Antigen (PSA)21. Squamous Cell Carcinoma Antigen (SCC)22. T and B Lymphocytes23. TdT24. Thyroglobulin25. Tissue Polypeptide Antigen (TPA)26. Biochemical Tumor MarkersADAB-ProteinPNP5-Nucleotidase27. OncogenesAbl/abl-bcrAIB1BCL-2BRCA1CD44C-fosC-mybC-mycCYP-17Erb-BHPC1N-mycP40P51P53PIK3CAPTI-1RasRegSisSrc28. Polypeptide Growth FactorsBasic Fibroblast Growth FactorBeta-TGF
  4. 4. Cachectin (TNT)CalmodulinECFRNerve Growth Factor (NGF)Epidermal Growth Factor (EGF)Ornithine DecarboxylaseTransferrinTransforming Growth Factor-Alpha29. Ectopic Hormones30. Colony Stimulating Factors31. LymphokinesAlpha-InterferonB Cell Growth FactorsB Cell Growth Factor (BCGF)Gamma-InterferonInterleukin-1 (IL-1)Macrophage Activating Factor32. Immunohistochemical Stains33. Emerging Tumor MarkersN-AcetylglucosamineActinAlpha-ActinAntineuronal Antibodies7B2B72.3BaxBCD-F9BLCA-4Blood Group Antigens A,B,HCA 50CA 72-4/TAG-72CA 195CA-242CA-549CAM 26CAR-3Cathepsin-DChromogranin A and BCluster 1 AntigenCluster-5/5A AntigenCTACU18
  5. 5. DR-70DU-PAN-2Endometrial Bleeding Associated FactorEndostatinEpithelial Membrane AntigenFeulgen HydrolysisFibronectinFSH(1->3)-L-fucosyltransferaseGastrin-Releasing Peptide (GRP)GDCFP-15GlucagonGlycoaminesH23Her-2Human Carcinoma AntigenHPAHSP27Intermediate FilamentsCytokeratins/CK18/Cyfra 21-1DesminGliofibrillary Acid ProteinNeurofilamentsVimentinKA 93KinasesKP16D3LAILeukocyte Common AntigenLewis AntigensLysophosphatidic Acid (LPA)Ma 695/Ma 552MABDF3MAGME1MinactivinMN/CA9MSAMucin Cancer Antigen (MCA)Multiple Tumor Suppressor 1MyosinNEA-130
  6. 6. NMP22OA-519Opiod PeptidesP-glycoproteinPancreatic Oncofetal Antigen (POA)Placental LactogenPR92Proliferative Index, Ki-67PxRB Inactivation/DeletionRetSCCL 175SelectinSialic AcidSialyl SSEA-1/SLXSN10SomatostatinTA-90TABATachykininTAG 12TPSTroponinTubulinVCAMVEGFVillenC. Instrumentation Review And Market Needs1. Abbott AxSYM2. Abbott Architect c40003. Abbott Architect i2000 Series4. Abbott Architect ci8200 System5. Beckman Coulter UniCel Series6. Beckman Coulter Access7. Binding Site ESP6008. bioMerieux Mini Vidas9. Carolina Chemistries BioLis 24i10. DiaSorin Liaison11. Horiba ABX Pentra 40012. Inverness DS213. J&J Vitros ECi/ECiQ14. J&J Vitros 3600
  7. 7. 15. J&J Vitros 560016. Olympus AU540017. Olympus AU3000i18. Olympus AU270019. Roche Modular Analytics20. Roche Cobas Integra 40021. Roche Cobas Integra 400 Plus22. Roche Elecsys23. Roche Cobas c31124. Siemens ADVIA Centaur25. Siemens Dimension26. Siemens Dimension RxL Max27. Siemens Dimension Vista 50028. Siemens Immulite29. Siemens Stratus30. Tosoh AIA-Series31. Vital Diagnostics ATAC 800032. Vital Diagnostics Envoy 500D. Current and Emerging Technologies1. Monoclonal and Polyclonal Antibodies2. Immunoassaysa. Technological Principleb. Radioimmunoassay (RIA)c. Enzyme Immunoassays (EIA)OverviewELISAImmunofiltrationParticle-Membrane Capture ImmunoassayEnzyme Amplificationd. Fluorescent Immunoassayse. LuminescenceChemiluminescenceBioluminescencef. Latex Agglutinationg. ImmunoprecipitationH. Affinity Chromatographue. Liposome Flow-Injection Immunoassay3. Molecular Diagnosticsa. Technology Overviewb. Amplification MethodsPCRDAP-PCR
  8. 8. Immuno-PCRQC-PCRCARDNAHPALCRNASBAQBRSDA3 SR, and others4. Chromosome Analysisa. Chronic Myelogenous Leukemia (CML)b. Acute Myeloid Leukemia (AML)c. Acute Lymphoblastic Leukemia (ALL)d. Malignant LymphomasLymphoid Malignanciese. Chronic Lymphocytic Leukemia (CLL)f. Solid Cancersg. Chromosomal Translocation and Oncogenes5. Artificial Intelligence6. Flow Cytometry7. Two Dimensional Gel Electrophoresis (2-DGE)8. Biosensors9. Competing/Complementing Technologiesa. CTb. MRIc. NMRd. PETe. Photonics SpectroscopyFranceA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersGermanyA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersItalyA. Executive SummaryB. Business Environment
  9. 9. C. Market StructureD. Market Size, Growth and Major SuppliersSpainA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersU.K.A. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development OpportunitiesA. Reagent Kits and Test Systems/PanelsB. InstrumentationC. Computers, Software and AutomationD. Auxiliary ProductsDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market Segmentation FactorPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive ProfilesAbbottAdnaGenApplied Gene Technologies
  10. 10. ArcaBeckman Coulter/DanaherBecton DickinsonBiomedical DiagnosticsbioMerieuxBio-RadCepheidCorrelogic SystemsDakoDecodeDiadexusDiagnocureDiasorinEiken ChemicalEnterixEnzo BiochemEpigenomicsExact SciencesFujirebioGen-ProbeGuided TherapeuticsHologicIpsogenKreatechKyowa MedexLife TechnologiesMackay Life SciencesMyriad GeneticsNanogen ElitechOncoLabOrtho-Clinical DiagnosticsPanacea PharmaceuticalsPolartechnicsPolymedcoPreMDQiagenRadient PharmaceuticalsRocheScienionSequenomSiemens HealthcareTakara Bio
  11. 11. Targeted Diagnostics & TherapeuticsTosohVeridexWako Pure ChemicalsWallac/PEZilaAppendixesAppendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technologyand ApplicationsAppendix II: Assumed Currency Exchange RatesList Of TablesTumor Marker ClassificationMajor Companies Developing or MarketingACTH TestsMajor Companies Developing or MarketingAFP TestsMajor Companies Developing or MarketingBeta-2 Microglobulin TestsMajor Companies Developing or MarketingCA 15-3/27.29 TestsMajor Companies Developing or MarketingCA 19-9 TestsMajor Companies Developing or MarketingCA 125 TestsMajor Companies Developing or MarketingCalcitonin TestsMajor Companies Developing or MarketingCEA TestsMajor Companies Developing or MarketingEstrogen Receptor TestsMajor Companies Developing or MarketingProgesterone Receptor TestsMajor Companies Developing or MarketingFerritin TestsMajor Companies Developing or MarketingGastrin TestsMajor Companies Developing or MarketingHCG TestsMajor Companies Developing or MarketingInsulin Tests
  12. 12. Major Companies Developing or MarketingNSE TestsMajor Companies Developing or MarketingOccult Blood TestsMajor Companies Developing or MarketingPAP Smear/HPV TestsMajor Companies Developing or MarketingPAP TestsMajor Companies Developing or MarketingPSA TestsMajor Companies Developing or MarketingLymphocyte Subclassification TestsBiochemical Markers Potential ApplicationsIn Cancer DiagnosisOncogenes Potential ApplicationsIn Cancer DiagnosisMajor Companies Developing or MarketingOncogene TestsGrowth Factors Potential ApplicationsIn Cancer DiagnosisColony Stimulating Factors PotentialApplications in Cancer DiagnosisLymphokines Potential ApplicationsIn Cancer DiagnosisImmunohistochemical Stains PotentialApplications in Cancer DiagnosisExecutive Summary Table: France, Total CancerDiagnostic Test Volume and Sales Forecastby Market SegmentFrance, Estimated Cancer Death RatesPer 100,000 PopulationFrance, Laboratories Performing TumorMarker Tests by Market SegmentFrance, Hospital Laboratories PerformingTumor Marker Tests by Bed SizeFrance, Commercial/Private LaboratoriesPerforming Tumor Markersby Annual Test VolumeFrance, Total Tumor Marker Test VolumeForecast by Market SegmentFrance, All Market Segments Major TumorMarker Test Volume Forecast
  13. 13. France, Hospital Laboratories Major TumorMarker Test Volume Forecast by TestFrance, Commercial/Private LaboratoriesMarker Test Volume ForecastFrance, Total Tumor Marker Sales Major TumorForecast by Market SegmentFrance, All Market Segments Major TumorMarker Sales Forecast by TestFrance, Hospital Laboratories Major TumorMarker Sales Forecast by TestFrance, Commercial/Private Laboratories CancerDiagnostics Market Forecast by TestFrance, ACTH Test Volume and Diagnostics SalesForecast by Market SegmentFrance, AFP Test Volume and Diagnostics SalesForecast by Market SegmentFrance, Beta-2 Microglobulin Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, CA 15-3/27.29 Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, CA 19-9 Test Volume and DiagnosticsSales Forecast by MarketFrance, CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, Calcitonin Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, Cathepsin Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, CEA Test Volume and Diagnostics SalesForecast by Market SegmentFrance, Colon-Specific Antigen Test VolumeAnd Diagnostics Sales Forecastby Market SegmentFrance, Cytokeratins Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Estrogen Receptor Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Ferritin Test Volume
  14. 14. and Diagnostics Sales Forecastby Market SegmentFrance, Gastrin Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, HCG Test Volume and Diagnostics SalesForecast by Market SegmentFrance, Insulin Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Interferons Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Interleukins Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Lymphocyte Subtyping Test VolumeAnd Diagnostics Sales Forecastby Market SegmentFrance, NSE Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, Nucleolar Test Volume and DiagnosticsSales Forecast by Market SegmentFrance, Occult Blood Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Oncogenes Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Pancreatic Oncofetal AntigenTest Volume and Diagnostics SalesForecast by Market SegmentFrance, PAP Smear Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Parathyroid Hormone Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Progesterone Receptor Test VolumeAnd Diagnostics Sales Forecastby Market SegmentFrance, PAP Test Volume and Diagnostics Sales
  15. 15. Forecast by Market SegmentFrance, PSA Test Volume and Diagnostics SalesForecast by Market SegmentFrance, S-100 Protein Test Volumeand Sales Diagnostics Sales Forecastby Market SegmentFrance, Serotonin Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Sialic Acid Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, Squamous Cell Carcinoma AntigenTest Volume and Diagnostics SalesForecast by Market SegmentFrance, TDT Test Volume and Diagnostics SalesForecast by Market SegmentFrance, Thymidine Kinase Test VolumeAnd Diagnostics Sales Forecastby Market SegmentFrance, Thyroglobulin Test Volumeand Diagnostics Sales Forecastby Market SegmentFrance, TPA Test Volume and Diagnostics SalesForecast by Market SegmentFrance, Total Tumor Marker SalesBy Major SuppliersFrance, AFP Testing Market DiagnosticsSales by Major SupplierFrance, CA 15-3 Testing Market DiagnosticsSales by Major SupplierFrance, CA 19-9 Testing Market DiagnosticsSales by Major SupplierFrance, CA 125 Testing Market DiagnosticsSales by Major SupplierFrance, CEA Testing Market DiagnosticsSales by Major SupplierFrance, NSE Testing Market DiagnosticsSales by Major SupplierFrance, PAP Testing Market DiagnosticsSales by Major SupplierFrance, PSA Testing Market Diagnostics
  16. 16. Sales by Major SupplierExecutive Summary Table: Germany, TotalTumor Marker Test Volume and Sales ForecastBy Market SegmentGermany, Estimated Cancer Death RatesPer 100,000 PopulationGermany, Laboratories Performing TumorMarker Tests by Market SegmentGermany, Hospital Laboratories PerformingTumor Marker Tests by Bed SizeGermany, Commercial/Private LaboratoriesPerforming Tumor Markers by AnnualTest VolumeGermany, Total Tumor Marker Test VolumeForecast by Market SegmentGermany, All Market Segments, Major TumorMarker Test Volume ForecastGermany, Hospital Laboratories,Major Tumor Marker Test Volume Forecastby TestGermany, Commercial/Private LaboratoriesMajor Tumor Marker Test Volume ForecastGermany, Physician Offices/GroupPractices Major Tumor MarkerTest Volume ForecastGermany, Total Tumor Marker SalesForecast by Market SegmentGermany, All Market Segments Major TumorMarker Sales Forecast by TestGermany, Hospital Laboratories, Major TumorMarker Sales Forecast by TestGermany, Commercial/Private LaboratoriesMajor Tumor Marker Sales Forecast by TestGermany, Physician Offices/Group PracticesMajor Tumor Marker Sales Forecast by TestGermany, ACTH Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, AFP Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Beta-2 Microglobulin Test VolumeAnd Diagnostics Sales Forecastby Market Segment
  17. 17. Germany, CA-15-3/27.29 Test Volume andDiagnostics Sales Forecast by Market SegmentGermany, CA-19 Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, CA 125 Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Calcitonin Test VolumeAnd Diagnostic Sales Forecastby Market SegmentGermany, Cathepsin Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, CEA Test Volume and Diagnostics SalesForecast by Market SegmentGermany, Chromogranin Test VolumeAnd Diagnostics Sales Forecast by Market SegmentGermany, Colon-Specific Antigen Test VolumeAnd Diagnostics Sales Forecastby Market SegmentGermany, Cytokeratins Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Estrogen Receptor Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Ferritin Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Gastrin Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, HCG, Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Interferons Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Interleukins Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, NSE Test Volume and Diagnostics
  18. 18. Sales Forecast by Market SegmentGermany, Occult Blood Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Oncogenes Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Pancreatic Oncofetal AntigenTest Volume and Diagnostics SalesForecast by Market SegmentGermany, Pap Smear Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Parathyroid Hormone Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Progesterone Receptor Test VolumeAnd Diagnostics Sales Forecastby Market SegmentGermany, PAP Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, PSA Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, S-100 Protein Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Serotonin Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Sialic Acid Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Squamous Cell Carcinoma AntigenTest Volume and Diagnostics Sales ForecastBy Market SegmentGermany, TDT Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Thymidine Kinase Test Volumeand Diagnostics Sales Forecastby Market SegmentGermany, Thyroglobulin Test Volumeand Diagnostics Sales Forecast
  19. 19. by Market SegmentGermany, TPA Test Volume and DiagnosticsSales Forecast by Market SegmentGermany, Total Tumor Marker SalesBy Major SupplierGermany, AFP Testing Market DiagnosticsSales by Major SupplierGermany CA 15-3/27.29 Testing MarketDiagnostics Sales by Major SupplierGermany CA 19-9 Testing Market DiagnosticsSales by Major SupplierGermany, CA 125 Testing Market DiagnosticsSales by Major SupplierGermany, CEA Testing Market DiagnosticsSales by Major SupplierGermany, PSA Testing Market DiagnosticsSales by Major SupplierExecutive Summary Table: Italy, Total TumorMarker Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Estimated Cancer Death RatesPer 100,000 PopulationItaly, Laboratories Performing TumorMarker Tests by Market SegmentItaly, Hospital Laboratories PerformingTumor Marker Tests by Bed SizeItaly, Commercial/Private LaboratoriesPerforming Tumor Markersby Annual Test VolumeItaly, Total Tumor Marker Test VolumeForecast by Market SegmentItaly, All Market Segments Major CancerDiagnostic Test Volume ForecastItaly, Hospital Laboratories Major TumorMarker Test Volume ForecastItaly, Commercial/Private LaboratoriesMajor Tumor Marker Test Volume ForecastItaly, Total Tumor Marker Test MarketForecast by Market SegmentItaly, All Market Segments Major TumorMarker Sales Forecast by TestItaly, Hospital Laboratories Major
  20. 20. Tumor Marker Forecast by TestItaly, Commercial/Private LaboratoriesMajor Tumor Marker Sales Forecastby TestItaly, ACTH Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, AFP Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Beta-2 Microglobulin Test VolumeAnd Diagnostics Sales Forecastby Market SegmentItaly, CA 15-3/27.29 Test Volumeand Diagnostics Sales Forecastby Market SegmentItaly, CA-19-9 Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, CA 125 Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Calcitonin Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, CEA Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Chromogranin Test VolumeAnd Diagnostics Sales Forecast by Market SegmentItaly, Colon Specific Antigen Test VolumeAnd Diagnostics Sales Forecastby Market SegmentItaly, Cytokeratins Test Volumeand Diagnostics Sales Forecastby Market SegmentItaly, Estrogen Receptor Test Volumeand Diagnostics Sales Forecastby Market SegmentItaly, Ferritin Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Gastrin Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, HCG Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Lymphocyte Subtyping Test Volume
  21. 21. And Diagnostics Sales Forecastby Market SegmentItaly, NSE Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Occult Blood Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Oncogenes Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Pancreatic Oncofetal Antigen TestVolume and Diagnostics Sales Forecastby Market SegmentItaly, PAP Smear Test Volumeand Diagnostics Sales Forecastby Market SegmentItaly, Parathyroid Hormone Test Volumeand Diagnostics Sales Forecastby Market SegmentItaly, Progesterone Receptor Test Volumeand Diagnostics Sales Forecastby Market SegmentItaly, PAP Test Volume and Diagnostics SalesForecast by Market SegmentItaly, PSA Test Volume and Diagnostics SalesForecast by Market SegmentItaly, S-100 Test Volume and DiagnosticsSales Forecast by Market SegmentItaly, Serotonin Test Volumeand Diagnostics Sales Forecastby Market SegmentItaly, Sialic Acid Test Volumeand Diagnostics Sales Forecastby Market SegmentItaly, Squamous Cell Carcinoma Antigen TestVolume and Diagnostics Sales Forecastby Market SegmentItaly, TDT Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Thymidine Kinase Test Volumeand Diagnostics Sales Forecastby Market SegmentItaly, Thyroglobulin Test Volumeand Diagnostics Sales Forecast
  22. 22. by Market SegmentItaly, TPA Test Volume and Diagnostics SalesForecast by Market SegmentItaly, Total Tumor MarkersSales by Major SuppliersItaly, AFP Testing Market DiagnosticsSales by Major SupplierItaly, CEA Testing Market DiagnosticsSales by Major SupplierItaly, PSA Testing Market DiagnosticsSales by Major SupplierExecutive Summary Table: Spain, TotalTumor Marker Test Volume and SalesForecast by Market SegmentSpain, Estimated Cancer Death RatesPer 100,000 PopulationSpain, Laboratories Performing TumorMarker Tests by Market SegmentSpain, Hospital Laboratories PerformingTumor Marker Tests by Bed SizeSpain, Commercial/Private LaboratoriesPerforming Tumor Markers by Annual Test VolumeSpain, Total Tumor Marker Test VolumeForecast by Market SegmentSpain, All Market Segment Major CancerDiagnostic Test Volume ForecastSpain, Hospital Laboratories Major CancerDiagnostic Test Volume Forecast by TestSpain, Commercial/Private LaboratoriesMajor Tumor Marker Test Volume ForecastSpain, Total Tumor Marker SalesForecast by Market SegmentSpain, All Market Segments Major TumorMarker Sales Forecast by TestSpain, Hospital Laboratories Major TumorMarker Sales Forecast by TestSpain, Commercial/Private Laboratories MajorTumor Marker Sales Forecast by TestSpain, AFP Test Volume and Diagnostics SalesForecast by Market SegmentSpain, Beta-2 Microglobulin Test Volume andDiagnostics Sales Forecast by Market Segment
  23. 23. Spain, CA 15-3 Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, CA 19-9 Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Calcitonin Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, CEA Test Volume and Diagnostics SalesForecast by Market SegmentSpain, Colon-Specific Antigen Test Volumeand Diagnostics Sales Forecastby Market SegmentSpain, Estrogen Receptor Test Volumeand Diagnostics Sales Forecastby Market SegmentSpain, Ferritin Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Gastrin Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, HCG Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Lymphocyte SubtypingTest Volume and DiagnosticsSales Forecast by Market SegmentSpain, NSE Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Occult Blood Test Volumeand Diagnostics Sales Forecastby Market SegmentSpain, Oncogenes Test Volumeand Diagnostics Sales Forecastby Market SegmentSpain, Pancreatic Oncofetal AntigenTest Volume and DiagnosticsSales Forecast by Market SegmentSpain, PAP Smear Test Volumeand Diagnostics Sales Forecastby Market SegmentSpain, Parathyroid Hormone Test Volume
  24. 24. And Diagnostics Sales Forecastby Market SegmentSpain, Progesterone ReceptorTest Volume and Diagnostics Sales Forecastby Market SegmentSpain, PAP Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, PSA Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, S-100 Protein Test VolumeAnd Diagnostics Sales Forecastby Market SegmentSpain, Serotonin Test Volumeand Diagnostics Sales Forecastby Market SegmentSpain, Sialic Acid Test Volumeand Diagnostics Sales Forecastby Market SegmentSpain, Squamous Cell Carcinoma AntigenTest Volume and Diagnostics Sales Forecastby Market SegmentSpain, TDT Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Thymidine KinaseTest Volume and DiagnosticsSales Forecast by Market SegmentSpain, ThyroglobulinTest Volume and DiagnosticsSales Forecast by Market SegmentSpain, TPA Test Volume and DiagnosticsSales Forecast by Market SegmentSpain, Total Tumor Marker Salesby Major SuppliersSpain, AFP Testing Market DiagnosticsSales by Major SupplierSpain, CA 15-3/27.29 Testing MarketDiagnostics Sales by Major SupplierSpain, 19-9 Testing Market DiagnosticsSales by Major SupplierSpain, CA 125 Testing Market DiagnosticsSales by Major SupplierSpain, CEA Testing Market Diagnostics
  25. 25. Sales by Major SupplierSpain, PSA Testing Market DiagnosticsSales by Major SupplierExecutive Summary Table: U.K., TotalTumor Marker Test Volume and SalesForecast by Market SegmentU.K., Estimated Cancer Death RatesPer 100,000 PopulationU.K., Laboratories Performing TumorMarker Tests by Market SegmentU.K., Hospital Laboratories PerformingTumor Marker Tests by Bed SizeU.K., Commercial/Private LaboratoriesPerforming Tumor Marker Testsby Annual Test VolumeU.K., Total Tumor Marker Testing VolumeForecast by Market SegmentU.K., All Market Segments MajorTumor Marker Test Volume ForecastU.K., Hospital Laboratories MajorTumor Marker Test Volume Forecastby TestU.K., Commercial/Private LaboratoriesMajor Tumor Marker Test Volume ForecastU.K., Total Tumor Marker SalesForecast by Market SegmentU.K., All Market Segments MajorTumor Marker Sales Forecast by TestU.K., Hospital Laboratories MajorTumor Marker Sales Forecast by TestU.K., Commercial/Private LaboratoriesMajor Tumor Marker Sales Forecastby TestU.K., ACTH Test Volume and Diagnostics SalesForecast by Market SegmentU.K., AFP Test Volume and Diagnostics SalesForecast by Market SegmentU.K., Beta-2 Microglobulin Test Volumeand Diagnostics Sales Forecastby Market SegmentU.K., CA 15-3/27.29 Test Volumeand Diagnostics Sales Forecast
  26. 26. by Market SegmentU.K., CA 19-9 Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., CA-125 Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Calcitonin Test Volumeand Diagnostics Sales Forecastby Market SegmentU.K., CEA Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Chromogranin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Colon-Specific Antigen Test VolumeAnd Diagnostics Sales by Market SegmentU.K., Cytokeratins Test Volumeand Diagnostics Sales Forecastby Market SegmentU.K., Estrogen Receptor Test Volumeand Diagnostics Sales Forecastby Market SegmentU.K., Ferritin Test Volumeand Diagnostics Sales Forecastby Market SegmentU.K., Gastrin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., HCG Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Insulin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Lymphocyte Subtyping Test Volumeand Diagnostics Sales Forecastby Market SegmentU.K., NSE Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Occult Blood Test Volumeand Diagnostics Sales Forecastby Market SegmentU.K., Oncogenes Test Volumeand Diagnostics Sales Forecastby Market SegmentU.K., Pancreatic Oncofetal AntigenTest Volume and Diagnostics
  27. 27. Sales Forecast by Market SegmentU.K., PAP Smear Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Parathyroid HormoneTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., Progesterone ReceptorTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., PAP Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., PSA Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., S-100 Protein Test Volumeand Diagnostics Sales Forecastby Market SegmentU.K., Serotonin Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Sialic Acid Test Volumeand Diagnostics Sales Forecastby Market SegmentU.K., Squamous Cell Carcinoma AntigenTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., TDT Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Thymidine KinaseTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., ThyroglobulinTest Volume and DiagnosticsSales Forecast by Market SegmentU.K., TPA Test Volume and DiagnosticsSales Forecast by Market SegmentU.K., Total Tumor Marker Salesand Market Shares ForecastU.K., CEA Testing Market DiagnosticsSales by Major SupplierU.K., PSA Testing Market DiagnosticsSales by Major Supplier
  28. 28. Contact: sales@reportsandreports.com for more information.

×